Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:39310rdf:typepubmed:Citationlld:pubmed
pubmed-article:39310lifeskim:mentionsumls-concept:C0026549lld:lifeskim
pubmed-article:39310lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:39310lifeskim:mentionsumls-concept:C0178601lld:lifeskim
pubmed-article:39310lifeskim:mentionsumls-concept:C0026606lld:lifeskim
pubmed-article:39310lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:39310lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:39310lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:39310lifeskim:mentionsumls-concept:C1627358lld:lifeskim
pubmed-article:39310pubmed:issue3lld:pubmed
pubmed-article:39310pubmed:dateCreated1979-11-28lld:pubmed
pubmed-article:39310pubmed:abstractTextAniamls were administered increasing doses of morphine for 16 days. During withdrawal they were challenged with an apomorphine ester or lergotrile. These dopamine agonists produced quantitatively different effects on behaviour. The results suggest that chronic morphine administration leads to dopamine supersensitivity which may be anatomically distinct in origin.lld:pubmed
pubmed-article:39310pubmed:languageenglld:pubmed
pubmed-article:39310pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:39310pubmed:citationSubsetIMlld:pubmed
pubmed-article:39310pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:39310pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:39310pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:39310pubmed:statusMEDLINElld:pubmed
pubmed-article:39310pubmed:monthMaylld:pubmed
pubmed-article:39310pubmed:issn0033-3158lld:pubmed
pubmed-article:39310pubmed:authorpubmed-author:TyeN CNClld:pubmed
pubmed-article:39310pubmed:authorpubmed-author:PullarI AIAlld:pubmed
pubmed-article:39310pubmed:authorpubmed-author:WrightF CFClld:pubmed
pubmed-article:39310pubmed:authorpubmed-author:HorsmanLLlld:pubmed
pubmed-article:39310pubmed:issnTypePrintlld:pubmed
pubmed-article:39310pubmed:day15lld:pubmed
pubmed-article:39310pubmed:volume63lld:pubmed
pubmed-article:39310pubmed:ownerNLMlld:pubmed
pubmed-article:39310pubmed:authorsCompleteYlld:pubmed
pubmed-article:39310pubmed:pagination313-5lld:pubmed
pubmed-article:39310pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:39310pubmed:meshHeadingpubmed-meshheading:39310-An...lld:pubmed
pubmed-article:39310pubmed:meshHeadingpubmed-meshheading:39310-Mo...lld:pubmed
pubmed-article:39310pubmed:meshHeadingpubmed-meshheading:39310-Ra...lld:pubmed
pubmed-article:39310pubmed:meshHeadingpubmed-meshheading:39310-Ma...lld:pubmed
pubmed-article:39310pubmed:meshHeadingpubmed-meshheading:39310-Ap...lld:pubmed
pubmed-article:39310pubmed:meshHeadingpubmed-meshheading:39310-Ti...lld:pubmed
pubmed-article:39310pubmed:meshHeadingpubmed-meshheading:39310-Do...lld:pubmed
pubmed-article:39310pubmed:meshHeadingpubmed-meshheading:39310-Mo...lld:pubmed
pubmed-article:39310pubmed:meshHeadingpubmed-meshheading:39310-Er...lld:pubmed
pubmed-article:39310pubmed:meshHeadingpubmed-meshheading:39310-Dr...lld:pubmed
pubmed-article:39310pubmed:year1979lld:pubmed
pubmed-article:39310pubmed:articleTitleDifferential enhancement of locomotor activity by dopamine agonists following chronic morphine treatment.lld:pubmed
pubmed-article:39310pubmed:publicationTypeJournal Articlelld:pubmed